This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Today's Outrage: Caught With Their Pants Down

Stocks in this article: Q GS

(Qwest, Galleon Group, Goldman insider trading story updated with new SEC case)

NEW YORK ( TheStreet) -- Let's call it the case of white collar crime meeting the waistline.

Former Qwest Communications (Q) CEO Joseph Nacchio, currently serving a 70-month sentence for selling $52 million worth of stock based on insider information, is suing his former defense team at Roseland, N.J.-based Stern & Kilcullen. The former Qwest CEO alleges that among the $25 million in billings from his former legal team, he footed the bill for tens of thousands of dollars in breakfasts, in-room movie rentals charged to hotel room bills, and yes, attorney underwear purchases, according to a court complained made by the former Qwest CEO's complaint in state Superior Court in Newark, N.J., and reviewed last week by Bloomberg.

There are also some actual legal charges made in the case, such as professional negligence and the failure of the Naccio's lawyers to use a key witness who might have prevented a conviction. Yet the part about the underwear bilking may prove what happens when a smart guy who is dumb enough to get embroiled in insider trading is sent to jail for 70 months; he's got too much time in the prison library to review his own case (and he's probably pretty jealous of those on the outside able to watch movies in hotel rooms while in their silk underwear).

It was a busy week in the world of insider trading last week, too. Goldman Sachs (GS) CEO Lloyd Blankfein made for the biggest white collar crime headline, when he took the stand in the case against Galleon Group founder Raj Rajaratnam. Blankfein testified that former Goldman Sachs director Raj Gupta violated the investment bank's confidentiality policy in passing on information to the Galleon Group manager.

The financial press was on the edge of its collective seat during Blankfein's testimony, with bloggers furiously posting with each step that Blankfein took towards the witness stand -- "he's on the stand right now!" There was at least a minor embarrassment for the Goldman Sachs CEO as Blankfein had to listen to lawyers read out loud from Goldman's praise of Gupta when he resigned from the board. Yet the Blankfein testimony was much ado about some typical legal back-and-forth, with Blankfein noting that Goldman's code of conduct does not address whether confidential information is the same as "material inside information," the legal standard for insider trading, and the Goldman CEO stating that at the time of the statement about Gupta's resignation he really did know all that much about the allegations.

The insider trading focus from regulators shows no sign of slowing down, either, with a new case brought by the Securities and Exchange Commission on Tuesday against an FDA scientist accused of generating $3.6 million in illicit profits by trading with advanced knowledge on at least 27 public FDA drug approval decisions involving 19 publicly traded companies.

When it comes to the hedge funds and biotech community (and one Goldman Sachs former director), there seems to be a mistaken belief that profiting from privileged information is a legal right of society's most privileged. The new SEC case against the FDA chemist follows a case launched last November against a French doctor accused of serving as an insider information conduit between drug trials and hedge funds.

Which brings us back to the exciting world of insider traders getting the shaft when high-priced lawyers buy designer underwear at Barney's.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,906.42 +101.62 0.57%
S&P 500 2,073.62 +2.97 0.14%
NASDAQ 4,773.5410 +8.1610 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs